Novartis FY25Q4 results
Based on the Novartis Q4 2025 Media Release, here is the high-level summary of the financial and operational performance: Full Year 2025 Financial Results Novartis delivered strong performance in 2025, driven by double-digit growth in core products: Key Growth Drivers (Full Year Sales) The following products contributed significantly to the revenue growth: Pipeline and Strategic […]
Novartis – History and Competitions
Novartis has a rich history originating from three Swiss companies in Basel, evolving through several distinct stages: 1. The Roots: Three Independent Pioneers (1758–1970) Novartis traces its lineage to three chemical and pharmaceutical firms: Core Products: Core Strategy: Revenue Level: 2. Mergers and the Birth of Novartis (1970–1996) This period marked the transition from chemicals […]